MEA Fluoroscopy Market

MEA Fluoroscopy Market Size (2024 to 2029)

The size of the Fluoroscopy Market in the Middle East and Africa is estimated to worth USD 36.62 million by 2029 and USD 30.77 million in 2024, growing at a CAGR of 3.54% during the forecast period.

During surgical or orthopedic operations, C-arms are typically utilized for fluoroscopy imaging. Fluoroscopy-c arms are medical imaging equipment that uses x-ray technology as their foundation. Fluoroscopy-c arms provide high-resolution real-time pictures. The growth in the fluoroscopy market is majorly driven by the use of fluoroscopy in pain management, proliferation of chronic diseases, and growing geriatric population across Middle East Africa. The other factors, such as the advantages of FPDS over the image intensifiers and reimbursement cuts for analog radiography systems, are projected to propel the market. The growing demand for minimally invasive procedures is one of the main reasons driving the market growth in the Middle East and Africa. Furthermore, the growing incidence of cardiovascular illnesses in the Middle East and Africa is a major driver of market growth.

Moreover, increasing healthcare expenditure, improving healthcare infrastructure in developing countries such as South Africa, UAE, AND Saudi Arabia are most likely to influence the market growth. The fluoroscopy-C arms market will have profitable and remunerative development prospects as personal disposable income rises.

Furthermore, the rising adoption of advanced technologies, including machine learning and artificial intelligence in the healthcare industry and developed markets, increases the fluoroscopy market in Middle East Africa.  According to a 2016 report, about 210 individuals die from heart disease in South Africa every day. This is owing to a general lack of knowledge about cardiovascular disease. In addition, South Africa has one of the world's highest rates of overweight and obesity, which is a risk factor for the illness.  Noncommunicable illnesses (lifestyle-related disorders), such as heart disease, are responsible for 43% of adult fatalities in the nation. Furthermore, according to Statistics South Africa, roughly 4.38 million South Africans suffered from hypertension in 2018, making it the country's most common chronic health condition. As per the World Health Organization, chronic illnesses such as cancer, heart disease, and renal failure would become the leading causes of mortality in Sub-Saharan Africa by 2030, accounting for 42 percent of all deaths in the area, up from 25 percent in 2014. (WHO).

However, radiation-related adverse effects, the risk of radiation exposure connected with fluoroscopy-c arms, on the other hand, will slow the market growth. Furthermore, the high prices connected with fluoroscopy-c arms will be a major hurdle in the future, slowing the market development pace. The fluoroscopy-C arms mark will be hampered by a lack of a suitable reimbursement environment in emerging and undeveloped nations.

This research report on the Middle East and Africa Fluoroscopy Market has been segmented and sub-segmented into the following categories

By Surgery Type

• Cardiovascular interventions
• Biopsy
• Orthopedic surgeries
• Others

By End User

• Hospitals
• Diagnostic centers
• Clinics

By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA fluoroscopy market is expected to account for a substantial share in the global market during the forecast period due to a consistent number of strategic alliances targeted at creating new generations of products. Also, the growing number of minimally invasive surgeries, improving healthcare infrastructure, and growing demand for advanced diagnostics across the region are propelling the market growth. The emerging economies in this region, such as South Africa, Saudi Arabia, and UAE, are majorly contributing to the regional market growth. Over the forecast period, South Africa dominated the Fluoroscopy Market. The market growth is attributed to the rising disposable income, government initiatives and funding, growing base of the obese population across the country. As a result, the burden of cardiovascular disease is quickly rising throughout Africa, and it is already a major public health concern across the country.  South Africa has one of the world's highest rates of overweight and obesity, which is a risk factor for the illness. According to the World Health Organization, hypertension, stroke, cardiomyopathies, and coronary heart disease are some of the most common cardiovascular illnesses. In fact, after HIV/Aids, heart disease and stroke are the second biggest killers in South Africa.

KEY MARKET PLAYERS

A few of the promising companies leading the MEA Fluoroscopy market profiled in this report are Philips Healthcare, GE Healthcare, Siemens Medical Solutions, Shimadzu Medical Systems, Shanghai Bojin Medical Instrument Co., Ltd, and Toshiba Medical Systems Corp.